These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
175 related items for PubMed ID: 7896192
1. Identification of E6/E7 transcription patterns in HPV 16-positive cervical cancers using the reverse transcription/polymerase chain reaction. Rose BR, Thompson CH, Tattersall MH, Elliott PM, Dalrymple C, Cossart YE. Gynecol Oncol; 1995 Feb; 56(2):239-44. PubMed ID: 7896192 [Abstract] [Full Text] [Related]
3. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis. Wang-Johanning F, Lu DW, Wang Y, Johnson MR, Johanning GL. Cancer; 2002 Apr 15; 94(8):2199-210. PubMed ID: 12001118 [Abstract] [Full Text] [Related]
4. [Detection of high-risk human papillomavirus (HPV) E6 and E7 oncogene transcripts increases the specificity of the detection of a cervical intraepithelial neoplasia (CIN)]. Sotlar K, Diemer D, Stubner A, Menton S, Menton M, Dietz K, Wallwiener D, Bültmann B. Verh Dtsch Ges Pathol; 2005 Apr 15; 89():195-200. PubMed ID: 18035691 [Abstract] [Full Text] [Related]
5. Fragile histidine triad transcription abnormalities and human papillomavirus E6-E7 mRNA expression in the development of cervical carcinoma. Segawa T, Sasagawa T, Yamazaki H, Sakaike J, Ishikawa H, Inoue M. Cancer; 1999 May 01; 85(9):2001-10. PubMed ID: 10223242 [Abstract] [Full Text] [Related]
6. HPV-16-related proteins as the serologic markers in cervical neoplasia. Park JS, Park DC, Kim CJ, Ahn HK, Um SJ, Park SN, Kim SJ, Namkoong SE. Gynecol Oncol; 1998 Apr 01; 69(1):47-55. PubMed ID: 9570998 [Abstract] [Full Text] [Related]
7. In vitro antigene therapy targeting HPV-16 E6 and E7 in cervical carcinoma. Madrigal M, Janicek MF, Sevin BU, Perras J, Estape R, Peñalver M, Averette HE. Gynecol Oncol; 1997 Jan 01; 64(1):18-25. PubMed ID: 8995542 [Abstract] [Full Text] [Related]
9. [Molecular biologic study on the carcinogenesis of HPV in uterine cervical cancer and related lesions--analysis of HPV types 16, 18 E6/E7 gene mRNA]. Nagai N. Nihon Sanka Fujinka Gakkai Zasshi; 1990 Aug 01; 42(8):823-33. PubMed ID: 2172419 [Abstract] [Full Text] [Related]
12. Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference. Jiang M, Milner J. Oncogene; 2002 Sep 05; 21(39):6041-8. PubMed ID: 12203116 [Abstract] [Full Text] [Related]
14. Human papillomavirus-related serological markers of invasive cervical carcinoma in Brazil. Sun Y, Eluf-Neto J, Bosch FX, Muñoz N, Booth M, Walboomers JM, Shah KV, Viscidi RP. Cancer Epidemiol Biomarkers Prev; 1994 Jun 05; 3(4):341-7. PubMed ID: 8061584 [Abstract] [Full Text] [Related]
15. Adenovirus-mediated transfer of human papillomavirus 16 E6/E7 antisense RNA and induction of apoptosis in cervical cancer. Hamada K, Shirakawa T, Gotoh A, Roth JA, Follen M. Gynecol Oncol; 2006 Dec 05; 103(3):820-30. PubMed ID: 16908054 [Abstract] [Full Text] [Related]
16. Adenovirus-mediated transfer of HPV 16 E6/E7 antisense RNA to human cervical cancer cells. Hamada K, Sakaue M, Alemany R, Zhang WW, Horio Y, Roth JA, Mitchell MF. Gynecol Oncol; 1996 Nov 05; 63(2):219-27. PubMed ID: 8910631 [Abstract] [Full Text] [Related]
17. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells. Sima N, Wang S, Wang W, Kong D, Xu Q, Tian X, Luo A, Zhou J, Xu G, Meng L, Lu Y, Ma D. Gynecol Oncol; 2007 Aug 05; 106(2):299-304. PubMed ID: 17586029 [Abstract] [Full Text] [Related]